Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
0.00 (0.00%)
At close: Feb 24, 2026
-95.29%
Market Cap 3.06M
Revenue (ttm) 10.88K
Net Income (ttm) -2.93M
Shares Out 76.57M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Average Volume 48,545
Open 0.0400
Previous Close n/a
Day's Range 0.0400 - 0.0400
52-Week Range 0.0300 - 1.2500
Beta -0.05
RSI 28.80
Earnings Date May 28, 2026

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.